Mary Lynn McPherson
speaker
498 appearances
2 recordings
1 series
first heard Oct 2018
last heard Dec 2021
Mary Lynn McPherson’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
way longer than the publisher would have liked.
The first edition the first edition took about two years, I would say, um, because I I have a lot else going on.
But um this was really hard to do because there's as you know very well know, there's very little consensus.
And then with the second edition, which and I was longer getting that done that they would have liked as well.
Uh but to my benefit, I think, and to the benefit of the book.
Uh, we're finally getting better data about doing these calculations.
So I think it significantly better informed the second edition.
So I was really pleased with it.
Well, I think there are always questions about methadone dosing.
That's probably the drug that scares people the most.
But other than that, it's kind of all over the place.
Like I was just at in Texas at MD Anderson giving a lecture on open conversions and one of the physicians asked about now that we're getting better data looking at steady state conversions as opposed to single dose crossover trials and healthy normy normal people, do you still have to reduce for cross tolerance?
And you don't, but that raises the question, how do you know from those equally analgesic tables?
When you do have to reduce and when you should don't need to reduce.
So I think people are very confused about that.
When do I need to reduce for lack of cross tolerance?
Which really gets it's a much more complicated question.
Is the patient in pain?
Is the patient not in pain?
What's their clinical situation?
Showing 41–60 of 498 · page 3 of 25
← Previous
Next →